NP56326 Service for Peritoneal Dialysis Treatments

The Common Services Agency, more commonly known as NHS National Services Scotland (NSS), is currently in the tender stage for the provision of a homecare delivery service for peritoneal dialysis treatments. The project, titled "NP56326 Service for Peritoneal Dialysis Treatments," falls under the pharmaceutical products category (CPV: 33600000) and is primarily for goods procurement. This open procedure is set in Edinburgh, Scotland, and covers regions in the UKM area under the framework agreement.

The tender submission deadline has been extended to 18th February 2026, allowing more time for interested parties to submit bids. Award decisions are scheduled to take place starting 12th February 2026. The procurement process aims to deliver essential medical services directly to patients' homes, including the supply of dialysis machines and necessary consumables.

Businesses specialising in pharmaceutical products, homecare service delivery, logistics, and medical devices are well-positioned to compete for this contract. Given the scale of the contract, with a value of £14,000,000 GBP and a duration of 48 months, opportunities exist for companies that can demonstrate strong supply chain management, sustainability practices, and compliance with Scottish regulatory requirements. Suppliers with innovative delivery solutions, robust business continuity planning, and the capability to deliver community benefits will find significant growth potential.

The multi-supplier framework welcomes entities that can serve up to 200 NHS Scotland patients, providing a consistent healthcare service to support outpatient treatment at home. The inclusion of community benefits as part of this procurement process underscores NHS Scotland’s commitment to integrating broader societal impacts into its healthcare service delivery.